Credit Suisse maintains Merck at 'outperform' with a price target of EUR180.00

An analyst from Credit Suisse maintained Merck (ETR: MRCG ) at 'outperform' with a price target of EUR180.00 from a prior price target of %currency%%price%.
Prior to this rating, Merck had 13 buy ratings, 3 hold ratings, and 0 sell ratings.
For consensus analyst estimates and price targets on Merck, click here. For more news on Merck, click here.
Merck's stock price closed at $160.40. They are down -0.12% in the last month and down -0.48% in the last 12 months.
According to Investing Pro, Merck's fair value is $198.36, an upside of 23.67%. Merck's fair value comes with a low degree of uncertainty, according to InvestingPro.
Check out Merck's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or